<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03894423</url>
  </required_header>
  <id_info>
    <org_study_id>IRB-49945</org_study_id>
    <secondary_id>1R01HL141712-01A1</secondary_id>
    <secondary_id>MZ-0048352</secondary_id>
    <nct_id>NCT03894423</nct_id>
  </id_info>
  <brief_title>Comprehensive Computed Tomography Guidance of Coronary Bypass Graft Surgery</brief_title>
  <official_title>Comprehensive CT Guided Coronary Bypass Graft Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>VA Palo Alto Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Apply CT angiography, CT perfusion imaging and advanced image processing techniques to&#xD;
      improve revascularization decision-making and surgical strategies in patients undergoing&#xD;
      coronary artery bypass graft surgery.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to integrate noninvasively acquired anatomical and functional&#xD;
      information to develop clinically applicable tools for meaningful per-vessel&#xD;
      revascularization decisions. The decisions will be based on quantitative lesion-specific&#xD;
      ischemia and viability and flow simulations. These will be based on CT anatomy enhanced with&#xD;
      a function for prediction of hemodynamic improvement after CABG.&#xD;
&#xD;
      Aim 1: Predict restoration of myocardial perfusion from coronary artery bypass graft surgery.&#xD;
      The investigators will perform cardiac CT before and after CABG and measure absolute changes&#xD;
      in myocardial perfusion as the functional outcome of CABG. The investigators will investigate&#xD;
      clinical, surgical and imaging variables in association with post-CABG perfusion improvement&#xD;
      on a per-vessel and per-patient level.&#xD;
&#xD;
      Aim 2: Non-invasively quantify vessel-specific ischemia for meaningful CABG decisions.&#xD;
&#xD;
      The investigators will develop and validate tools for assessment of vessel-specific ischemia&#xD;
      and viability. The investigators will assess the potential impact of CT guided CABG by&#xD;
      comparing the per-vessel need for grafting with standard care.&#xD;
&#xD;
      Aim 3: Predict CABG benefit through multi-parameter flow simulations Hypothesis: Integration&#xD;
      of myocardial perfusion and viability can improve flow simulation models to predict CABG&#xD;
      outcome. The investigators will develop new computational fluid dynamics models enriched with&#xD;
      functional parameters and explore the potential of virtual grafting to improve hemodynamic&#xD;
      outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">July 2023</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in myocardial blood flow from baseline measured by cardiac CT</measure>
    <time_frame>2 Months</time_frame>
    <description>Myocardial blood flow will be measured by dynamic stress CT perfusion imaging before and 2 months after CABG. The primary endpoint is the difference MBF values between both examinations, per coronary distribution.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Bypass graft obstruction by cardiac CT</measure>
    <time_frame>2 Months</time_frame>
    <description>The presence of bypass grafts obstruction will be assessed on CT angiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in angina pectoris assessed by SAQ</measure>
    <time_frame>1 Year</time_frame>
    <description>Severity of anginal complaints will be assessed using the Seattle Angina Questionnaire before and 1 year after CABG.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>CAD</condition>
  <condition>Atheroscleroses, Coronary</condition>
  <condition>Computed Tomography</condition>
  <condition>Coronary Artery Bypass</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients scheduled to undergo coronary bypass graft surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Planned elective CABG for coronary artery disease.&#xD;
&#xD;
          -  CABG is the primary indication for surgery (but may include treatment of mild-moderate&#xD;
             valvular disease).&#xD;
&#xD;
          -  Age: â‰¥40 years.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Technical feasibility of the cardiac CT exams: redo-CABG, significant&#xD;
             arrhythmia/mal-conduction, congenital conditions, severe valvular disease or&#xD;
             cardiomyopathy (to the extent that the CT acquisition is technically challenged),&#xD;
             inadequate understanding of the English language (to provide consent or follow&#xD;
             instructions during the exams).&#xD;
&#xD;
          -  Overall safety: unstable clinical condition (clinical heart failure, unstable angina,&#xD;
             myocardial infarction &lt;1 month prior).&#xD;
&#xD;
          -  Radiation risk: pregnancy (cannot be ruled out), body weight &gt;100kg.&#xD;
&#xD;
          -  CT contrast medium-related: known allergy, renal failure&#xD;
&#xD;
          -  Vasodilator related: known allergy, bronchial asthma requiring daily use of&#xD;
             bronchodilators, Mobitz II or 3rd degree AV block, sick sinus node disease, clinically&#xD;
             significant carotid artery narrowing, severe aortic stenosis or LVOT narrowing,&#xD;
             systolic blood pressure below 90mmHg, (continued) use of dipyridamole or&#xD;
             aminophylline.&#xD;
&#xD;
          -  Inability to provide informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Koen Nieman, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gerri O'Riordian, RN</last_name>
    <phone>(650) 725-5597</phone>
    <email>gor@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Palo Alto Veterans Affaird Healthcare System</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grace Liang</last_name>
    </contact>
    <investigator>
      <last_name>Patricia Nguyen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94304</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sujana Balla, MBBS</last_name>
      <phone>650-736-4363</phone>
      <email>sujanaballa@stanford.edu</email>
    </contact>
    <investigator>
      <last_name>Koen Nieman, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of California San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Andrew Kahn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 22, 2019</study_first_submitted>
  <study_first_submitted_qc>March 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 28, 2019</study_first_posted>
  <last_update_submitted>March 15, 2021</last_update_submitted>
  <last_update_submitted_qc>March 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Koen Nieman</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No current plan to share data</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

